# JLK, Inc.

- Location (FDA's records): Seoul, KR
- FDA decisions: 8 (2024–2026): 8 510(k) clearances
- Product codes: QAS (4), LLZ (3), QIH (1)
- 510(k) review time since 2016: median 84 days, against 131 for FDA's reviews in the same codes and years (5 of 8 faster)
- Predicates its devices cite: 8 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Ischemaview, Inc.: 3 (https://510kreport.com/company/ischemaview)
- Viz. Ai, Inc.: 3 (https://510kreport.com/company/viz-ai)
- Quantib B.V.: 1 (https://510kreport.com/company/quantib)
- Infinitt Co., Ltd.: 1 (https://510kreport.com/company/infinitt)

## Recent decisions
- K252421: JLK-NCCT (Mar 24, 2026)
- K243611: JLK-SDH (Mar 3, 2025)
- K250348: JLK-AILink (Feb 25, 2025)
- K243363: JLK-Ich (Jan 3, 2025)
- K242709: JLK-Pwi (Nov 4, 2024)
- K242556: JLK-CTP (Oct 16, 2024)
- K241480: JBS-Lvo (Sep 27, 2024)
- K233196: Medihub Prostate (Jun 21, 2024)

Source page: https://510kreport.com/company/jlk